Evidence of improved reporting of swine vaccination trials in the post-REFLECT statement publication period by Moura, Cesar A. A. et al.
Veterinary Diagnostic and Production Animal
Medicine Publications
Veterinary Diagnostic and Production Animal
Medicine
9-2019
Evidence of improved reporting of swine
vaccination trials in the post-REFLECT statement
publication period
Cesar A. A. Moura
Iowa State University, moura@iastate.edu
Sarah Totton
Jan M. Sargeant
University of Guelph
Terri L. O’Sullivan
University of Guelph
Daniel C. L. Linhares
Iowa State University, linhares@iastate.edu
See next page for additional authors
Follow this and additional works at: https://lib.dr.iastate.edu/vdpam_pubs
Part of the Large or Food Animal and Equine Medicine Commons, and the Veterinary
Toxicology and Pharmacology Commons
The complete bibliographic information for this item can be found at https://lib.dr.iastate.edu/
vdpam_pubs/142. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Veterinary Diagnostic and Production Animal Medicine at Iowa State University Digital
Repository. It has been accepted for inclusion in Veterinary Diagnostic and Production Animal Medicine Publications by an authorized administrator
of Iowa State University Digital Repository. For more information, please contact digirep@iastate.edu.
Evidence of improved reporting of swine vaccination trials in the post-
REFLECT statement publication period
Abstract
Objectives: Describe and compare the proportion of studies reporting the method used to assign study units
to treatment groups, reporting a random allocation approach, reporting 18 REFLECT items, and the
proportion of studies having a low risk-of-bias assessment in swine vaccination trial studies published after the
REFLECT statement, compared to studies published before.
Materials and Methods: The study population was 61 studies that evaluated vaccines targeted at pathogens
affecting swine health or pork safety. Two reviewers assessed the reporting of 18 of 22 REFLECT items and 5
risk-of-bias domains.
Results: Authors reported the method used to allocate experimental units in 33 of 42 (79%) and 14 of 19
(74%) studies published prior to and following REFLECT, respectively. There has been a substantial shift in
the reporting of allocation approaches. Before 2011, only 2 of 25 (8%) studies that reported using random
allocation provided supporting evidence. This increased in studies published between 2011-2017 (4 of 6;
66%). Before 2011, 8 of 33 (24%) studies reported using systematic allocation, which increased to 43% (6 of
14 studies) between 2011-2017. There has also been an increase in the prevalence of reporting for 14 of the 18
REFLECT items. There was an increase in the number of studies reporting evidence to support true
randomization to group and data that suggests few baseline imbalances.
Implications: Data from this study suggests swine vaccination trial reporting improved, which may be due to
researchers having more access to better quality information.
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Summary
Objectives: Describe and compare the 
proportion of studies reporting the method 
used to assign study units to treatment 
groups, reporting a random allocation ap­
proach, reporting 18 REFLECT items, and 
the proportion of studies having a low risk­
of­bias assessment in swine vaccination trial 
studies published after the REFLECT state­
ment, compared to studies published before. 
Materials and Methods: The study popula­
tion was 61 studies that evaluated vaccines 
targeted at pathogens affecting swine health 
or pork safety. Two reviewers assessed the 
reporting of 18 of 22 REFLECT items and 
5 risk­of­bias domains. 
Results: Authors reported the method used 
to allocate experimental units in 33 of 42 
(79%) and 14 of 19 (74%) studies published 
prior to and following REFLECT, respec­
tively. There has been a substantial shift 
in the reporting of allocation approaches. 
Before 2011, only 2 of 25 (8%) studies that 
reported using random allocation provided 
supporting evidence. This increased in stud­
ies published between 2011­2017 (4 of 6; 
66%). Before 2011, 8 of 33 (24%) studies 
reported using systematic allocation, which 
increased to 43% (6 of 14 studies) between 
2011­2017. There has also been an increase 
in the prevalence of reporting for 14 of the 
18 REFLECT items. There was an increase 
in the number of studies reporting evidence 
to support true randomization to group and 
data that suggests few baseline imbalances. 
Implications: Data from this study suggests 
swine vaccination trial reporting improved, 
which may be due to researchers having 
more access to better quality information. 
Keywords: swine, REFLECT, vaccine, risk­
of­bias, randomization. 
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Resumen - Evidencia de un mejor reporte 
de los estudios de vacunación porcina en 
el período posterior de publicación a la 
declaración REFLECT
Objetivos: Describir y comparar la propor­
ción de estudios que describen el método 
utilizado para asignar unidades de estudio 
a grupos de tratamiento, que reportan un 
enfoque de asignación aleatoria, reportando 
18 ítems REFLECT y la proporción de estu­
dios que tienen una evaluación de bajo riesgo 
de parcialidad en estudios de vacunación 
porcina publicados después de la declaración 
REFLECT, comparados con estudios publi­
cados anteriormente.
Materiales y métodos: La población del 
estudio fue de 61 estudios que evaluaron va­
cunas contra patógenos que afectan la salud 
de los cerdos o la seguridad de la carne. Dos 
revisores evaluaron el informe de 18 de los 
22 elementos REFLECT y 5 áreas de riesgo 
de parcialidad.
Resultados: Los autores reportaron el 
método utilizado para asignar unidades ex­
perimentales en 33 de 42 (79%) y 14 de 19 
(74%) estudios publicados antes y después 
de REFLECT, respectivamente. Ha habido 
un cambio importante en el reporte de los 
enfoques de asignación. Antes de 2011, solo 
2 de 25 (8%) estudios que informaron el uso 
de una asignación aleatoria proporcionaron 
evidencia de apoyo. Esto aumentó en los 
estudios publicados entre 2011­2017 (4 de 
6; 66%). Antes de 2011, 8 de 33 (24%) estu­
dios informaron el uso sistemático, que au­
mentó a 43% (6 de 14 estudios) entre 2011­
2017. También ha habido un aumento en la 
prevalencia de reporte de 14 de los 18 ítems 
REFLECT. Hubo un aumento en el número 
de estudios que informaron evidencia para 
respaldar la asignación al azar real al grupo y 
los datos que sugieren pocos desequilibrios 
de base.
Implicaciones: Los datos de este estudio 
sugieren que los reportes de los estudios de 
vacunación porcina mejoraron, lo que puede 
deberse a que los investigadores tienen más 
acceso a información de mejor calidad. 
Résumé – Évidence d’amélioration de la 
publication des essais de vaccination des 
porcs durant la période suivant la publica-
tion de l’énoncé REFLECT
Objectifs: Décrire et comparer la pro­
portion d’études rapportant : la méthode 
utilisée pour attribuer les unités à l’étude 
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Infectious diseases of swine and infec­tious causes of foodborne illness impact the sustainability of the food supply. 
Diseases such as African swine fever, porcine 
reproductive and respiratory syndrome, 
and swine influenza can lead to reduced 
pork supply,1 while outbreaks of foodborne 
pathogens associated with pork, such as Sal-
monella, lead to reduced demand and risk of 
public health­related problems.2­4 Therefore, 
it is critical that swine veterinarians have 
access to comprehensive reports of vaccine 
efficacy, allowing them to make science­
driven decisions on the best immunization 
process to control or eradicate diseases in 
the herd. Unfortunately, scientific reporting 
of intervention studies in swine production 
often lacks critical information that enables 
assessment of biases, and there is an apparent 
need to improve reporting.5
In 2010, the Reporting Guidelines for Ran­
domized Controlled Trials for Livestock and 
Food Safety (REFLECT) statement and the 
companion Explanation and Elaboration 
document were published.6­11 The RE­
FLECT statement has a 22­item checklist 
developed by an international group to help 
investigators improve the reporting of live­
stock trials that have a production, health, or 
food­safety outcome. The long­term goal of 
reporting checklists such as the REFLECT 
statement and similar reporting guidelines, 
such as the CONSORT statement,12 the 
ARRIVE statement for biomedical experi­
ments,13­17 and STROBE­Vet,18­22 is to 
reduce research wastage and maximize re­
search utility for decision­making through 
improved reporting. Therefore, it is criti­
cal to periodically evaluate reporting and 
determine if progress toward improved 
reporting is occurring. In 2018, a study was 
performed to assess the reporting character­
istics of bovine respiratory disease clinical 
trials published before and following the 
publication of the REFLECT statement. 
The authors reported positive trends toward 
improved reporting after 2010.23 However, 
to our knowledge, there are no studies in 
swine production assessing if reporting has 
improved in recent years coinciding with 
efforts such as the REFLECT statement 
and Meridian Network (https://merid-
ian.cvm.iastate.edu), a website that acts 
as a clearinghouse for reporting guidelines 
related to animals used in research. 
Reporting guidelines are designed to im­
prove reporting with an underlying hope 
that once reporting is improved, end­users 
will be able to identify well­executed stud­
ies and clearly extract the results. It is also 
hoped that in reality the vast majority of 
studies are well executed, and that compre­
hensive reporting will enable this fact to be 
more obvious. Currently, it is often not pos­
sible to differentiate well­executed studies 
from poorly executed studies. If reporting 
is noncomprehensive then it is difficult, if 
not impossible, to differentiate between 
well­executed studies with a low risk­of­bias 
from poorly executed studies with a high 
risk­of­bias. For example, if 2 studies exist 
and one randomized properly and the other 
did not and neither reported randomization, 
then these differential risks­of­bias cannot 
be determined. However, not all aspects of 
reporting relate to risk­of­bias; some items 
are included to help end­users understand 
the generalizability of the results while 
other aspects are designed to help end­users 
properly comprehend the efficacy of the 
interventions. The lack of detail in reporting 
means that many studies with interventions 
of interest cannot be properly assessed by 
veterinarians, thus reducing the impact and 
utility of these studies. These aspects are still 
relevant as they ensure maximized utility 
of resources, including animals, involved in 
animal studies. 
The objective of this study was to assess 
whether reporting and risk­of­bias standards 
have changed for swine vaccination trials in 
the publication period from 2011 to 2017 
(post­REFLECT) compared to the publica­
tion period before 2011 (pre­REFLECT). 
Aim 1 described the proportion of studies 
reporting the allocation of study units to 
treatment group in studies published after 
the REFLECT statement compared to stud­
ies published before. Our hypothesis was 
that the proportion of articles reporting the 
allocation methods would have increased 
in recent years, as awareness of the impact 
of poor reporting has increased. Aim 2 de­
scribed the proportion of studies reporting 
a random allocation approach in studies 
published after the REFLECT statement 
compared to studies published before. Our 
hypothesis was that the proportion of arti­
cles reporting a random allocation approach 
have increased in the last years; however, 
prior evidence suggests that there is some 
misunderstanding in the veterinary sciences 
of the difference between truly random and 
pseudo­random allocation approaches.23 
Aim 3 sought to describe the reporting 
prevalence of 18 REFLECT items in studies 
published after the REFLECT statement 
compared to studies published before. Our 
hypothesis was that the proportion of ar­
ticles reporting the REFLECT items have 
increased over the years. Aim 4 sought to de­
scribe the proportion of studies having a low 
risk­of­bias assessment in studies published 
after the REFLECT statement compared 
to studies published before. Our hypothesis 
was that the proportion of articles having a 
low risk­of­bias assessment have increased 
over the years. 
aux groupes de traitement, une approche 
d’attribution aléatoire, 18 items REFLECT, 
et la proportion d’études ayant un risque 
faible de biais d’évaluation dans les essais de 
vaccination de porcs publiés après l’énoncé 
REFLECT, comparativement aux études 
publiées avant.
Matériels et méthodes: La population 
étudiée consistait en 61 études qui ont évalué 
des vaccins ciblant des agents pathogènes af­
fectant la santé porcine ou la salubrité de la 
viande porcine. Deux réviseurs ont évalué la 
publication de 18 des 22 items REFLECT et 
cinq domaines de risque de biais.
Résultats: Les auteurs rapportaient la 
méthode pour distribuer les unités expéri­
mentales dans 33 des 42 (79%) et 14 des 
19 (74%) études publiées préalablement et 
après REFLECT, respectivement. Il y eu 
un changement notoire dans la publication 
des approches d’attribution. Avant 2011, 
seulement 2 des 25 (8%) des études qui rap­
portaient utiliser une attribution aléatoire 
fournissaient des preuves à cet effet. Ceci 
augmenta dans les études publiées entre 
2011­2017 (4 de 6; 66%). Avant 2011, 8 des 
33 (24%) études rapportaient utiliser une at­
tribution aléatoire, proportion qui augmenta 
à 43% (6 de 14 études) entre 2011­2017. 
Il y eu également une augmentation de la 
prévalence à rapporter pour 14 des 18 items 
REFLECT. Il y avait une augmentation dans 
le nombre d’études qui rapportaient des 
preuves pour supporter une réelle randomi­
sation pour regrouper et des données qui 
suggèrent peu de débalancements au départ.
Implications: Les données de la présente 
étude suggère que les rapports d’essais de vac­
cination chez le porc se sont améliorés, ce qui 
pourrait être dû au fait que les chercheurs ont 
accès à des information de meilleure qualité.
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Materials and methods
Study protocol 
A study protocol was developed and regis­
tered with the Open Science Framework.24 
For all aspects of the project (title and 
abstract screening, full­text screening, and 
risk­of­bias assessment), 2 reviewers inde­
pendently completed forms in DistillerSR 
(Evidence Partners, Ottawa, Canada). Con­
flicts between reviewers were resolved by 
discussion or, when consensus could not be 
reached, by consulting a third reviewer. The 
authorship on the title page of each article 
was redacted before evaluation; however, 
because of the small community of research­
ers in this subject area, it was not possible to 
ensure that blinding occurred. Additionally, 
the reviewers could not be blinded to pub­
lication dates because the date on which the 
study was conducted was usually reported 
in the Methods section and was part of the 
comprehensive reporting assessment (Items 
3 and 14). The screening form, the reporting 
assessment form, and the risk­of­bias form 
were pretested on 20, 2, and 4 studies respec­
tively. All forms are provided in the online 
supplementary materials (https://doi.
org/10.25380/iastate.7946732.v1).
Study population 
For this cross­sectional observational survey, 
the population of interest was controlled tri­
als where at least one study group received a 
vaccine targeting pathogens associated with 
swine health or food safety in pork. Further, 
the study had to be published in 1 of the 5 
journals that published the REFLECT state­
ment: Preventive Veterinary Medicine, Jour-
nal of Food Protection, Journal of Veterinary 
Internal Medicine, Journal of Swine Health 
and Production, and Zoonoses and Public 
Health. These journals were selected because 
they recommend authors to use the RE­
FLECT statement. The outcome reported 
by the investigators did not impact eligibil­
ity. Controlled trials were defined as having 
a concurrent/parallel comparison arm with 
either artificial challenge or natural infec­
tion. The publication periods were defined 
as pre­REFLECT, which included 2010 
and earlier, and post­REFLECT, which was 
2011 and later. As REFLECT was published 
in 2010, we considered studies published in 
2010 as being written before REFLECT. 
Screening assessment 
The literature search was conducted in Web 
of Science (Clarivate Analytics, United 
States) using the Centre for Agriculture and 
Bioscience International database using the 
search strategy presented in Table 1. Two 
levels of screening were used to identify eli­
gible manuscripts: title and abstract followed 
by the full text. 
Comprehensive reporting 
assessment 
The reporting assessment form was based on 
a form developed for a bovine respiratory 
disease study,23 which was in turn based on 
the REFLECT Statement6­11 and was modi­
fied for use in swine. We assessed reporting 
18 of the 22 REFLECT items (items 1 and 
3­19). Items 2, 20, 21, and 22 were consid­
ered too subjective for a consistent and valid 
assessment. Signaling questions and notes 
that guided the consistent assessment of the 
items are included with the forms in the on­
line supplementary materials (https://doi.
org/10.25380/iastate.7946732.v1).
Risk-of-bias assessment 
We used the Cochrane risk­of­bias 2.0 algo­
rithm25 to assess the risk­of­bias that arose 
from deviations from intended interven­
tions, from missing outcome data, from mea­
surement of the outcome, and from selection 
of the reported results. However, for assess­
ing the risk­of­bias due to randomization 
process, we modified the algorithm so that 
it followed the schema in Figure 1. The risk­
of­bias algorithm we used did not consider 
failure to report allocation concealment to 
be critical to assessing bias in swine vaccine 
trials, as is suggested by the Cochrane risk­
of­bias algorithm. We would propose that 
the Cochrane risk­of­bias algorithm authors 
consider the allocation concealment impor­
tant in human health because the knowledge 
of potential intervention might cause some 
recruiters to modify the allocation schedule. 
For example, Kahan et al,26 described the 
following: 
If a recruiter believes the next allocation 
will be the intervention, they may wait 
to enroll a very sick patient, as they do 
not want to ‘waste’ an intervention 
allocation on a relatively healthy patient 
who is less likely to need it. 
However, in swine vaccine studies, which 
are the topic of this study, we considered 
the probability that the recruiter had either 
differential personal attachment to the pig 
or a priori knowledge of the pig potential 
production value to be low. 
Therefore, we included the scenario where 
studies could fail to report allocation con­
cealment and random method of allocation 
and this would result in a different pathway, 
with lower risk­of­bias, than the Cochrane 
Risk of Bias (ROB) 2.0 algorithm. We also 
Table 1: Literature search for vaccination trials in swine from 1982-2017 conducted in Web of Science using the CABI  
database*
Search No. Search string No. of hits
1 Topic = (swine OR pig* OR piglet* OR gilt* OR boar* OR sow* OR weaner* OR hog* OR  porcine OR pork* OR Sus scrofa OR Sus domesticus)
645,575
2 Topic = (Vaccin* OR immuniz*) 149,140
3
Journals = (Preventive Veterinary Medicine OR Journal of Food Protection OR Journal of  
Veterinary Internal Medicine OR Swine Health and Production OR Journal of Swine Health and 
Production OR Zoonoses and Public Health) 
17,169
4 #1 AND #2 AND #3 239
*  Search was conducted September 28, 2017. 
CABI = Centre for Agriculture and Bioscience International.
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Figure 1: Risk-of-bias algorithm arising from the allocation process used for 61 extracted swine vaccine studies published pre- 
or post-REFLECT publication. Y = yes; PY = probably yes; N = no; PN = probably no; NI = no information.
Low risk
Was the allocation
sequence random?
Were there baseline
imbalances that suggest
a problem with
randomization?
Were there baseline
imbalances that suggest
a problem with
randomization?
Some concerns
High risk
Y/PY
Y/PY/NI
N/PN
N/PN
Y/PY/NI
N/PN/NI
 
considered that providing no information 
about baseline differences to be more similar 
in risk to having evidence of baseline imbal­
ances. 
Our risk­of­bias assessment algorithm for 
individual and cluster­randomized trials 
(which are the trials that conduct the ran­
domization at the group level, instead of at 
the individual animal level) are the same. 
Statistical analysis 
We estimated the prevalence ratios for the 
post­REFLECT publication period (nu­
merator) compared to the pre­REFLECT 
publication period (denominator) for:
• reporting of any allocation method 
(Aim 1), 
• reporting of a valid random alloca­
tion, given an allocation approach was 
reported (Aim 2), 
• reporting 18 of the REFLECT items 
(Aim 3), and 
• a low risk­of­bias assessment for the five 
bias domains (low versus high/some 
concerns; Aim 4). 
We did not conduct any null hypothesis test­
ing as they have limited value in an observa­
tional study of unknown pre­planned power. 
Additionally, since we sampled all available 
papers that met our eligibility criteria, we 
considered the population to be a census. 
Therefore, we did not calculate any measures 
of precision (confidence intervals), because 
we have no uncertainty about the point 
estimates reported. When we could not 
calculate the prevalence ratio due to zeros, 
we reported the results of a Fisher test for 
binomial proportions. All statistical analyses 
were done using R 3.4.1 program. 
Results
Screening for eligibility and charac-
teristics of included studies 
The search retrieved 239 records. One hun­
dred seventy­two records were excluded 
based on the title or abstract. Six papers 
were excluded based on the full­text as­
sessment. For the 61 manuscripts assessed, 
42 studies27­68 were published before the 
REFLECT statement (date range: 1982­
2010), while 19 studies69­87 were published 
between 2011 and 2017. Forty­seven tri­
als were published in the Journal of Swine 
Health and Production (formerly published 
as Swine Health and Production), 11 in Pre-
ventive Veterinary Medicine, 2 in Zoonoses 
and Public Health, and 1 in Journal of Food 
Protection. Only the Journal of Swine Health 
and Production and Preventive Veterinary 
Medicine had articles published from 2011 
to 2017, with 14 and 5 papers, respectively. 
Fifty­six studies had individual allocation 
to an intervention group and 5 studies were 
cluster­randomized trials. 
Aim 1: Reporting of an allocation 
method 
Investigators reported in the title, abstract, 
or methods section the method used to allo­
cate the experimental units to the interven­
tions in 33 of 42 (79%) and 14 of 19 (74%) 
studies in the pre­REFLECT and post­
REFLECT publication periods, respectively 
(Figure 2). The prevalence ratio was 0.94.
Aim 2: Approach to allocation 
reported 
This outcome was limited to studies that 
reported an allocation approach in Aim 1. 
For 25 of 33 (76%) studies published before 
2011 and 6 of 14 (43%) studies published 
between 2011­2017, the approach to al­
location was reported as random. Before 
2011, 23 of 25 (92%) studies that reported a 
random allocation approach did not provide 
any evidence of the randomization process, 
for example, the method used to generate 
the random allocation sequence, the method 
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Figure 2: Distribution of allocation approaches reported in 61 swine vaccine studies published pre- or post-REFLECT publication.
Eligible studies
n = 61
pre-REFLECT
n = 42
Random with
evidence
n = 2
Random without
evidence
n = 23
Systematic allocation
n = 8
Other = 0
Random with
evidence
n = 4
Random without
evidence
n = 2
Systematic allocation
n = 6
Other = 2
Allocation method
reported
n = 33
No allocation
methods reported
n = 9
post-REFLECT
n = 19
Allocation method
reported
n = 14
No allocation
methods reported
n = 5
used to implement the random allocation 
sequence, or who conducted the randomiza­
tion process. Yet, in the period from 2011­
2017, this number had decreased to 2 of 6 
(33%) studies (Figure 2). Before 2011, only 
2 of 25 (8%) studies that reported a random 
allocation approach provided evidence of the 
randomization process, and this increased 
in studies published between 2011 and 
2017 to 4 of 6 (67%). Of the studies that 
did report information about allocation, 8 
of the 33 studies (24%) published before 
2011 and 6 of 14 (43%) studies published 
between 2011 and 2017 reported using a 
systematic allocation method. In systematic 
random allocation approaches, the research­
er picks the first individual at random and 
keeps selecting the other subjects by alterna­
tion. Two studies published post­REFLECT 
reported another allocation method (non­
random and arbitrary selection). 
Journal of Swine Health and Production — September and October 2019270
Table 2: Reporting characteristics of 18 REFLECT statement items from 61 extracted swine vaccine studies published pre- or 
post-REFLECT publication
REFLECT reporting items
Published studies reporting, No. (%)
Prevalence 
ratio
Pre-REFLECT 
studies
Post-REFLECT 
studies
Item 1: In the Title or Abstract, did the investigators report that the 
study units were randomly allocated to the interventions? (eg, “random 
allocation”, “randomized”, or “randomly assigned”)
11/42 (26) 6/19 (32) 1.2 
Item 3: In the Methods, did the investigators report eligibility criteria 
for owner/managers and study units at each level of the organizational 
structure, and did they describe the settings and locations where the 
data were collected?
2/42 (5) 4/19 (21) 4.4 
Item 4: In the Methods, did the investigators give precise details of 
the interventions intended for each group, the level at which the 
intervention was allocated, and how and when interventions were 
administered? 
28/42 (67) 15/19 (79) 1.2 
Item 5: Did the investigators report the specific objectives and 
hypotheses of the study? 
6/42 (14) 2/19 (11) 0.7
Item 6: Did the investigators give clearly defined primary outcome 
measures and the levels at which they were measured, and, when 
applicable, any methods used to enhance the quality of the 
measurements? 
6/42 (14) 8/19 (42) 2.9 
Item 7: Did the investigators report how the sample size was 
determined and, when applicable, explain any interim analyses and 
stopping rules?
7/42 (17) 7/19 (37) 2.2 
Item 8: If the authors described an approach to allocation anywhere 
in the manuscript then did the investigators report the method used 
to generate the random allocation sequence at the relevant level of 
the organizational structure, including details of any restrictions (eg, 
blocking, stratification)?
2/25 (08) 4/6 (67) 8.3 
Item 9: Did the investigators report the method used to implement the 
random allocation sequence at the relevant level of the organizational 
structure, (eg, numbered containers), clarifying whether the sequence 
was concealed until interventions were assigned?
0/25 (0) 0/6 (0) *
Item 10: Did the investigators report who generated the allocation 
sequence, who enrolled study units, and who assigned study units to 
their groups at the relevant level of the organizational structure?
0/25 (0) 0/6 (0) *
Item 11: Did the investigators report whether those administering 
the interventions, caregivers, and those assessing the outcomes were 
blinded to group assignment?
15/42 (36) 12/19 (63) 1.8 
Item 12: Were statistical methods used to compare groups for all 
outcome(s)? Did the investigators clearly state the level of statistical 
analysis and methods used to account for the organizational structure 
(where applicable)? Were the methods for additional analyses, such as 
subgroup analyses and adjusted analyses reported?
34/42 (81) 17/19 (89) 1.1 
Item 13: In the Results, did the investigators report the flow of study 
units through each stage for each level of the organization structure of 
the study (a diagram is strongly recommended)? 
29/42 (69) 15/19 (79) 1.1 
Item 14: Did the investigators report dates defining the periods of 
recruitment and follow-up?
12/42 (29) 5/19 (26) 0.9
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Table 2 cont’d: Reporting characteristics of 18 REFLECT statement items from 61 extracted swine vaccine studies published 
pre- or post-REFLECT publication
REFLECT reporting items
Published studies reporting, No. 
(%)
Prevalence 
ratio
Pre-REFLECT 
studies
Post-REFLECT 
studies
Item 15: Did the investigators report the baseline demographic and 
clinical characteristics of each group, explicitly providing information 
for each relevant level of the organizational structure?
11/42 (26) 8/19 (42) 1.6 
Item 16: Did the investigators report the number of study units (de-
nominator) in each group included in each analysis? 
25/42 (60) 15/19 (79) 1.3 
Item 17: Did the investigators report a summary of results for each 
group, accounting for each relevant level of the organizational 
structure, and the estimated effect size and its precision?
1/42 (2) 3/19 (16) 6.6 
Item 18: For the studies with 2 or more arms, did the investigators 
address multiplicity by reporting any other analyses performed, 
including subgroup analyses and adjusted analyses, indicating those 
pre-specified and those exploratory?
8/28 (29) 6/12 (50) 1.75
Item 19: Did the investigators report all important adverse events or 
side effects in each intervention group?
4/42 (10) 2/19 (11) 1.1
* not calculated
 
Aim 3: Reporting of REFLECT 
checklist items 
The reporting characteristics for the RE­
FLECT checklist items are reported in 
Table 2 and Figure 3. After REFLECT 
publication, the prevalence of reporting the 
following REFLECT items had improved: 
randomization in the title and abstract 
(item 1), eligibility criteria for owner/man­
agers and study units and the description of 
settings (item 3), details of the interventions 
(item 4), primary outcome (item 6), how the 
sample size was calculated (item 7), method 
used to generate the random allocation 
sequence (item 8), whether or not blind­
ing was done (item 11), whether statistical 
methods were used (item 12), flow of study 
units through the study (item 13), baseline 
demographic and clinical characteristics 
of each group (item 15), number of study 
units used in analysis (item 16), summary 
of results for each group ­ estimated effect 
size and its precision (item 17), multiplicity 
(item 18), and adverse events or side effects 
(item 19). After REFLECT publication, 
the prevalence of reporting the objective 
and hypothesis (item 5) and dates defining 
the periods of recruitment and follow­up 
(item 14) decreased. Concealment of the 
allocation sequence (item 9) as well as who 
generated the allocation sequence/who 
enrolled study units/who assigned study 
units to their groups (item 10) were not 
reported for any of the 61 studies reviewed. 
Data about reporting characteristics of the 
challenge models (REFLECT item 4B) are 
not shown in Figure 3, as it could not be 
dichotomized, and these results are instead 
reported in Table 3. The percentage of chal­
lenge model studies was higher in studies 
published before 2011 (21 of 42 studies; 
50%) than between 2011 and 2017 (6 of 
19 studies; 32%). 
Aim 4: Risk-of-bias assessment 
Of the 61 manuscripts assessed, 5 were 
cluster­randomized and published before 
2011, so there were no cluster­randomized 
trials identified in the post­REFLECT 
period. The reporting characteristics of the 
61 extracted studies for the risk­of­bias as­
sessments are shown in Table 4. There was 
an increase in the prevalence of low risk­of­
bias studies, based on the randomization 
process domain, between the post­ and pre­
REFLECT studies. All the other risk­of­bias 
domains appeared to be unchanged. 
Discussion
One of the main advantages of randomized 
controlled trials is their ability to reduce 
confounding, a significant source of bias 
in the assessment of interventions.88 It is 
interesting therefore that the prevalence of 
reporting an allocation method to study 
units was virtually unchanged (or decreased) 
in the two publication periods (79% to 
74%). However, although the proportion of 
studies that reported using a random alloca­
tion method has decreased, the proportion 
of studies that reported using a systematic 
method has increased. This finding also oc­
curred in other veterinary studies.89 Two 
hypotheses might explain this finding: 1) 
that there has been a change in the approach 
to allocation away from random allocation 
to systematic allocation, and 2) that there 
has been a change in the language used to 
report systematic or haphazard allocation 
approaches in veterinary sciences. Studies 
that previously described the allocation 
method as random have changed the de­
scription of the method to reflect the actual 
approach ie, systematic allocation. The first 
hypothesis suggests that there was no report­
ing improvement on studies published after 
REFLECT. The second hypothesis suggests 
that reporting is improving, if the studies 
published before 2011 that used systematic 
or haphazard methods were misreporting or 
misrepresenting those approaches as random 
allocation. This latter hypothesis is support­
ed by the increase in the number of studies 
that provided evidence for the designation 
of random allocation from 8% to 66%.
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Figure 3: The prevalence comparison plot of 18 REFLECT items reported in 42 studies published before 2011 and 19 studies 
published between 2011 and 2017. Item 4B had multiple categories and is not included. Items 2 and 20 to 23 were considered 
too subjective for assessment and were not included.
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We attempted to identify in veterinary 
clinical trial texts where the concept of sys­
tematic or alternative allocation arose, and 
we cannot trace its origin. One study we are 
aware of discusses and recommends the use 
of alternative approaches as being equiva­
lent to random allocation and practical, ie, 
every­other­calf or odd­and­even number 
schemes.90 The authors suggested that valid 
random allocation is impractical in field 
settings and alternation could serve as a prac­
tical method under field conditions while 
still controlling confounding bias. We were 
not able to identify similar advice for swine 
studies, although apparently this approach is 
used commonly. What is unknown is if, and 
under what circumstances, a systematic alloca­
tion approach is an adequate replacement for 
random allocation. We were unable to find 
empirical evidence for this assumption.90 
Another interesting finding is the number 
of studies that reported using a random 
allocation approach while providing no 
support for this statement. Although the 
percentage of studies reporting a random 
allocation approach was higher before 2011, 
most of those studies did not report details 
of the randomization process (23 of 25). The 
majority of studies (4 of 6) reporting a ran­
dom allocation approach between 2011 and 
2017 provided some information to support 
the randomization process. This finding sug­
gests improved reporting. 
For Aim 3, the results show an increase in 
the prevalence of reporting most of the RE­
FLECT items and suggest that the overall 
to conduct trials. However, if evidence were 
found that some design elements identified 
by Cochrane ROB 2.0 are not relevant to 
livestock studies this would not be unprec­
edented. In human health, some groups have 
reported that some Cochrane risks­of­bias 
domains appear not to be related to empiri­
cal evidence of bias.92 
Although reporting has improved, there 
remains room for improvement on all RE­
FLECT items, since none of them were 
reported by all papers. However, it is un­
clear what would be the best way to make 
this improvement occur. The journals that 
published the studies all endorse the use of 
the REFLECT statement; however, none 
require a checklist be submitted or require 
that reviewers use REFLECT to assess the 
studies. Even if these journals did require 
that submitting authors include a completed 
reporting checklist there is no evidence that 
such an approach would improve report­
ing.93 We would propose that several next 
steps are needed. It is essential that increased 
education efforts in veterinary schools, 
graduate programs, and groups involved 
in post­graduation professional develop­
ment such as the American Association of 
Swine Veterinarians raise awareness of the 
value of improved reporting to veterinar­
ians, especially as prior studies have shown 
that many editors are unaware of reporting 
guidelines.94 These efforts will ensure that 
veterinarians are aware that poor reporting 
is associated with biased results and that 
veterinarians can recognize poor report­
ing. Further, more education of researchers 
Table 3: Reporting characteristics of swine vaccine challenge studies (item 4B of REFLECT statement) published pre- or post-
REFLECT publication.
Publication period
No. of challenge studies/ 
Total No. of studies (%)
No. of studies reporting item/ 
No. of challenge studies (%)
Pre-REFLECT studies 21/42 (50) 5/21 (24) – complete description: organism growth details,      
                     route of administration and dose of the organism
13/21 (62) – partial description: route of administration and  
                       dose of the organism
1/21 (5) – partial description: route of administration
2/21 (10) – partial description: seeder pigs
Post-REFLECT studies 6/19 (32) 2/19 (11) – complete description: description of organism  
                     growth details, route of administration and dose 
                     of the organism
4/19 (21) – route of administration and dose of the organism  
                     only
 
reporting of swine intervention trials has 
improved. It is less clear whether improved 
reporting has translated into lower risk­of­
bias. Although the risk­of­bias due to the 
randomization process appears to have de­
creased, the other risk­of­bias domains were 
unchanged. Even for the randomization 
process ROB domain, the evidence is poor 
because the low risk­of­bias was based on 
2 studies published between 2011 and 2017 
and 1 study before 2011.
Additional information is needed to deter­
mine if the increased reported use of system­
atic allocation is based on the tendencies of 
the industry and is, therefore, unlikely to 
change. It is also necessary to establish the 
true benefit of randomized over systematic 
allocation methods to determine if it is es­
sential to use truly random approaches.91 
One approach would be to assess if there are 
differences in effect sizes in systematically 
allocated versus randomly allocated studies. 
Arguing against the need for such evidence 
is the fact that proper randomization to 
group is the established standard for inter­
vention trials and the basis for inference. 
It is also not currently feasible to obtain 
empirical evidence that allocation conceal­
ment is associated with bias as there are too 
few studies that include this component for 
comparison to be made. Further, it is hard 
to envision veterinary schools and graduate 
programs teaching study design approaches 
that are not acceptable at the federal level for 
registration of drugs or vaccines, especially as 
so many livestock veterinarians are employed 
by the pharmaceutical and biologics industry 
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about the obligation to provide stakehold­
ers, including funding groups, veterinarians, 
and producers, with research reports that 
comprehensively describe the research is 
required. Providing comprehensive reports 
ensures that maximum value is obtained 
from the human and financial capital in­
vestment made in research studies. Also, 
very importantly, if the basic premise of the 
call for improved reporting is disputed, we 
would strongly support that such evidence 
be included in the peer­reviewed literature 
so that the role of comprehensive research 
reporting can be properly discussed among 
scientists and stakeholders. 
Implications 
• Substantially more studies are report­
ing the use of systematic allocation 
methods, and it is unclear if such an 
approach adequately ensures exchange­
able groups. 
• The prevalence of reporting a random 
allocation method decreased between 
the pre­ and post­REFLECT studies; 
however, the prevalence of evidence 
to support a claim that valid random 
allocation was used has increased.
• The prevalence of reporting most 
REFLECT items increased between the 
pre­ and post­REFLECT publication 
periods.
• The prevalence of low risk­of­bias due 
to the allocation approach might have 
increased between the pre­ and post­
REFLECT publication periods. Other 
risk­of­bias domains appear unchanged. 
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Conversion tables
Weights and measures conversions
Common (US) Metric To convert Multiply by
1 oz 28.35 g oz to g 28.4
1 lb (16 oz) 453.59 g lb to kg 0.45
2.2 lb 1 kg kg to lb 2.2
1 in 2.54 cm in to cm 2.54
0.39 in 1 cm cm to in 0.39
1 ft (12 in) 0.31 m ft to m 0.3
3.28 ft 1 m m to ft 3.28
1 mi 1.6 km mi to km 1.6
0.62 mi 1 km km to mi 0.62
1 in2 6.45 cm2 in2 to cm2 6.45
0.16 in2 1 cm2 cm2 to in2 0.16
1 ft2 0.09 m2 ft2 to m2 0.09
10.76 ft2 1 m2 m2 to ft2 10.8
1 ft3 0.03 m3 ft3 to m3 0.03
35.3 ft3 1 m3 m3 to ft3 35
1 gal (128 fl oz) 3.8 L gal to L 3.8
0.264 gal 1 L L to gal 0.26
1 qt (32 fl oz) 946.36 mL qt to L 0.95
33.815 fl oz 1 L L to qt 1.1
Temperature equivalents (approx)
°F   °C
32 0
50 10
60 15.5
61 16
65 18.3
70 21.1
75 23.8
80 26.6
82 28
85 29.4
90 32.2
102 38.8
103 39.4
104 40.0
105 40.5
106 41.1
212 100
˚F = (˚C × 9/5) + 32
˚C = (˚F - 32) × 5/9
Conversion chart, kg to lb (approx)
Pig size Lb Kg
Birth 3.3-4.4 1.5-2.0
Weaning 7.7 3.5
11 5
22 10
Nursery 33 15
44 20
55 25
66 30
Grower 99 45
110 50
132 60
Finisher 198 90
220 100
231 105
242 110
253 115
Sow 300 135
661 300
Boar 794 360
800 363
1 tonne = 1000 kg 
1 ppm = 0.0001% = 1 mg/kg = 1 g/tonne 
1 ppm = 1 mg/L
